Cost-Utility Analysis of Delayed-Release Dimethyl Fumerate For The Treatment of Relapsing-Remitting Multiple Sclerosis In Portugal
Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.2471
https://www.valueinhealthjournal.com/article/S1098-3015(15)04547-7/fulltext
Title :
Cost-Utility Analysis of Delayed-Release Dimethyl Fumerate For The Treatment of Relapsing-Remitting Multiple Sclerosis In Portugal
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)04547-7&doi=10.1016/j.jval.2015.09.2471
First page :
A758
Section Title :
Research Podium Presentations - Session 1 and Session 2
Open access? :
No
Section Order :
2352